136 related articles for article (PubMed ID: 2598993)
1. Determination of acetylator phenotype in Caucasians with caffeine.
Hildebrand M; Seifert W
Eur J Clin Pharmacol; 1989; 37(5):525-6. PubMed ID: 2598993
[TBL] [Abstract][Full Text] [Related]
2. Acetylation phenotypes and biological variation in a French Caucasian population.
Pontes ZB; Vincent-Viry M; Gueguen R; Galteau MM; Siest G
Eur J Clin Chem Clin Biochem; 1993 Feb; 31(2):59-68. PubMed ID: 8467011
[TBL] [Abstract][Full Text] [Related]
3. Acetylator phenotyping: the urinary caffeine metabolite ratio in slow acetylators correlates with a marker of systemic NAT1 activity.
Cribb AE; Isbrucker R; Levatte T; Tsui B; Gillespie CT; Renton KW
Pharmacogenetics; 1994 Jun; 4(3):166-70. PubMed ID: 7920698
[TBL] [Abstract][Full Text] [Related]
4. Lack of association between slow acetylator status and spontaneous lupus erythematosus.
Kumana CR; Chan MM; Wong KL; Wong RW; Kou M; Lauder IJ
Clin Pharmacol Ther; 1990 Aug; 48(2):208-13. PubMed ID: 2379389
[TBL] [Abstract][Full Text] [Related]
5. Determination of N-acetylation phenotyping in a Greek population using caffeine as a metabolic probe.
Asprodini EK; Zifa E; Papageorgiou I; Benakis A
Eur J Drug Metab Pharmacokinet; 1998; 23(4):501-6. PubMed ID: 10323334
[TBL] [Abstract][Full Text] [Related]
6. A simplified and rapid test for acetylator phenotyping by use of the peak height ratio of two urinary caffeine metabolites.
el-Yazigi A; Chaleby K; Martin CR
Clin Chem; 1989 May; 35(5):848-51. PubMed ID: 2566399
[TBL] [Abstract][Full Text] [Related]
7. HPLC method for rapid determination of acetylator phenotype by measuring urinary caffeine metabolites.
Klebovich I; Arvela P; Pelkonen O
J Pharm Biomed Anal; 1993 Oct; 11(10):1017-21. PubMed ID: 8305582
[TBL] [Abstract][Full Text] [Related]
8. A population and family study of N-acetyltransferase using caffeine urinary metabolites.
Bechtel YC; Bonaiti-Pellie C; Poisson N; Magnette J; Bechtel PR
Clin Pharmacol Ther; 1993 Aug; 54(2):134-41. PubMed ID: 8354022
[TBL] [Abstract][Full Text] [Related]
9. Segregation analyses of four urinary caffeine metabolite ratios implicated in the determination of human acetylation phenotypes.
Vincent-Viry M; Pontes ZB; Gueguen R; Galteau MM; Siest G
Genet Epidemiol; 1994; 11(2):115-29. PubMed ID: 8013893
[TBL] [Abstract][Full Text] [Related]
10. Polymorphic N-acetylation of a caffeine metabolite.
Grant DM; Tang BK; Kalow W
Clin Pharmacol Ther; 1983 Mar; 33(3):355-9. PubMed ID: 6825389
[TBL] [Abstract][Full Text] [Related]
11. Caffeine acetylator phenotyping during maturation in infants.
Pariente-Khayat A; Pons G; Rey E; Richard MO; D'Athis P; Moran C; Badoual J; Olive G
Pediatr Res; 1991 May; 29(5):492-5. PubMed ID: 1896253
[TBL] [Abstract][Full Text] [Related]
12. Acetylation polymorphism of caffeine in a Japanese population.
Hashiguchi M; Ebihara A
Clin Pharmacol Ther; 1992 Sep; 52(3):274-6. PubMed ID: 1526084
[TBL] [Abstract][Full Text] [Related]
13. Acetylator phenotypes of Saudi Arabians by a simplified caffeine metabolites test.
el-Yazigi A; Chaleby K; Martin CR
J Clin Pharmacol; 1989 Mar; 29(3):246-50. PubMed ID: 2723111
[TBL] [Abstract][Full Text] [Related]
14. Caffeine as a potential indicator for acetylator status.
Rankin RB; Hudson SA; Fell AF
J Clin Pharm Ther; 1987 Feb; 12(1):47-51. PubMed ID: 3449563
[TBL] [Abstract][Full Text] [Related]
15. Concordance between the deduced acetylation status generated by high-speed: real-time PCR based NAT2 genotyping of seven single nucleotide polymorphisms and human NAT2 phenotypes determined by a caffeine assay.
Rihs HP; John A; Scherenberg M; Seidel A; Brüning T
Clin Chim Acta; 2007 Feb; 376(1-2):240-3. PubMed ID: 17011540
[TBL] [Abstract][Full Text] [Related]
16. Relationship between metabolic phenotype of N-acetylation and bladder cancer.
Cui X; Guo R; Xu Z; Wang B; Li C
Chin Med J (Engl); 2000 Apr; 113(4):303-5. PubMed ID: 11775223
[TBL] [Abstract][Full Text] [Related]
17. [Determination of caffeine metabolite for the evaluation of N-acetyltransferase, CYP1A2 and xanthine oxidase activities].
Lu JF; Yi T; Cao XM; Zhuo HT; Ling SS
Yao Xue Xue Bao; 1997 Nov; 32(11):813-8. PubMed ID: 11596199
[TBL] [Abstract][Full Text] [Related]
18. Interindividual and intraindividual variability in acetylation: characterization with caffeine.
Hardy BG; Lemieux C; Walker SE; Bartle WR
Clin Pharmacol Ther; 1988 Aug; 44(2):152-7. PubMed ID: 3396262
[TBL] [Abstract][Full Text] [Related]
19. An alternative test for acetylator phenotyping with caffeine.
Tang BK; Kadar D; Kalow W
Clin Pharmacol Ther; 1987 Nov; 42(5):509-13. PubMed ID: 3677540
[TBL] [Abstract][Full Text] [Related]
20. Caffeine as a metabolic probe: validation of its use for acetylator phenotyping.
Tang BK; Kadar D; Qian L; Iriah J; Yip J; Kalow W
Clin Pharmacol Ther; 1991 Jun; 49(6):648-57. PubMed ID: 2060254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
